CD19 and cancer: Additionally, volcano plots of the differentially expressed genes in these cancers indicated that in the RAC1 low-expression group, the expression levels of B cell surface markers (such as CD19, CD79A, and MS4A1) and immunoglobulin-related genes (such as IGHG1 and CR2) were higher.